<SEC-DOCUMENT>0001628280-22-028167.txt : 20221103
<SEC-HEADER>0001628280-22-028167.hdr.sgml : 20221103
<ACCEPTANCE-DATETIME>20221103160131
ACCESSION NUMBER:		0001628280-22-028167
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20221103
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221103
DATE AS OF CHANGE:		20221103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGAMO THERAPEUTICS, INC
		CENTRAL INDEX KEY:			0001001233
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				680359556
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30171
		FILM NUMBER:		221357803

	BUSINESS ADDRESS:	
		STREET 1:		7000 MARINA BLVD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		5109706000

	MAIL ADDRESS:	
		STREET 1:		7000 MARINA BLVD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANGAMO BIOSCIENCES INC
		DATE OF NAME CHANGE:	20000208
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sgmo-20221103.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:2d4bcf69-489a-499c-93f0-33382d0e4c8a,g:8e31aed4-8033-4d31-b72e-faba0b6780e2,d:306798decccb43bf989c4ff8a9018965--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sgmo-20221103</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="icf870e24f0b84ae4a065fe4e9de2e33a_D20221103-20221103" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjMwNjc5OGRlY2NjYjQzYmY5ODljNGZmOGE5MDE4OTY1L3NlYzozMDY3OThkZWNjY2I0M2JmOTg5YzRmZjhhOTAxODk2NV80L2ZyYWc6YTVlNGZiNzI3ODk1NDY1MWEwNDlmNTc5YTJiMzkxY2EvdGFibGU6OGRkZDhjMzY3Yzg1NGExZDlkMDRlOGNkM2NmNWE5N2MvdGFibGVyYW5nZTo4ZGRkOGMzNjdjODU0YTFkOWQwNGU4Y2QzY2Y1YTk3Y18yLTEtMS0xLTU0MDc3_05ff59d6-acdb-4348-aaba-ea1f46009605">November 3, 2022</ix:nonNumeric><ix:nonNumeric contextRef="icf870e24f0b84ae4a065fe4e9de2e33a_D20221103-20221103" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjMwNjc5OGRlY2NjYjQzYmY5ODljNGZmOGE5MDE4OTY1L3NlYzozMDY3OThkZWNjY2I0M2JmOTg5YzRmZjhhOTAxODk2NV80L2ZyYWc6YTVlNGZiNzI3ODk1NDY1MWEwNDlmNTc5YTJiMzkxY2EvdGFibGU6OGRkZDhjMzY3Yzg1NGExZDlkMDRlOGNkM2NmNW